Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 916542 Boston, MA

Position in RLMD

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$4,959,278
+$2,415,231 QoQ
Shares Held
712,540
+35.3% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $703,385,515 across 179 Biotechnology names. RLMD ranks #27 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,959,278 712,540
2025-12-31 $2,544,047 526,718
2025-09-30 $1,170,911 582,543
2025-06-30 $371,687 619,479
2025-03-31 $331,540 1,227,928
2024-12-31 $638,522 1,227,928
2024-09-30 $3,844,104 1,186,452
2024-06-30 $3,579,999 1,193,333
2024-03-31 $5,492,514 1,181,186
2023-12-31 $4,896,895 1,182,825
2023-09-30 $3,518,169 1,172,723
2023-06-30 $3,004,641 1,221,399
2023-03-31 $2,760,361 1,221,399
2022-12-31 $3,840,183 1,100,339